FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Allan Hess

Research Profile

Disorders

Graft vs Host Disease

Procedures

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Erin L Schenk; B Douglas Smith; Brian D Koh; David Parry; Kevin L Peterson; Karen Flatten; Allan Hess; Larry M Karnitz; Judith E Karp; Scott H Kaufmann
Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.
Allan Hess
Equal opportunity targeting in chronic GVHD.
Mamta Gupta; Jing Jing Han; Andrea E Wahner Hendrickson; Allan Hess; Judith E Karp; Sharon Barr; Karen S Flatten; Brian D Koh; Kevin L Peterson; Paula A Schneider; Jennifer C Shing; B Douglas Smith; Mary J Stenson; Linda E Wellik; Thomas E Witzig; Seong Seok Yun; Scott H Kaufmann
Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Allan Hess (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Erin L Schenk; B Douglas Smith; Brian D Koh; David Parry; Kevin L Peterson; Karen Flatten; Allan Hess; Larry M Karnitz; Judith E Karp; Scott H Kaufmann
Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(19):5364-73.
2012: Allan Hess
Equal opportunity targeting in chronic GVHD.
Blood 2012;119(26):6183-4.
2012: Mamta Gupta; Jing Jing Han; Andrea E Wahner Hendrickson; Allan Hess; Judith E Karp; Sharon Barr; Karen S Flatten; Brian D Koh; Kevin L Peterson; Paula A Schneider; Jennifer C Shing; B Douglas Smith; Mary J Stenson; Linda E Wellik; Thomas E Witzig; Seong Seok Yun; Scott H Kaufmann
Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies.
Blood 2012;119(2):476-87.
2011: Christopher G Kanakry; Allan Hess; Christopher D Gocke; Christopher J Thoburn; FERDYNAND KOS; Christian Meyer; Janet Briel; Leo Luznik; B Douglas Smith; Hyam I Levitsky; Judith E Karp
Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells.
Blood 2011;117(2):608-17.
2010: Laura McGirt; Christopher J Thoburn; Allan Hess; Eric Vonderheid
Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome.
Photodermatology, photoimmunology & photomedicine 2010;26(4):182-91.
2010: Allan Hess
Reconstitution of self-tolerance after hematopoietic stem cell transplantation.
Immunologic research 2010;47(1-3):143-52.
2010: Julie M Wu; Christopher J Thoburn; JOSHUA WISELL; Evan Farmer; Allan Hess
CD20, AIF-1, and TGF-beta in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(5):720-8.
2010: Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert A Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette L Kasamon; Steven Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.
Blood 2010;115(16):3224-30.
2010: Allan Hess
Separation of GVHD and GVL.
Blood 2010;115(9):1666-7.
2010: Xue Wei Meng; Michael P Heldebrant; Karen Flatten; David Loegering; Haiming Dai; Paula A Schneider; Timothy Gomez; Kevin L Peterson; Sergey A Trushin; Allan Hess; B Douglas Smith; Judith E Karp; Daniel D Billadeau; Scott H Kaufmann
Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.
The Journal of biological chemistry 2010;285(2):888-902.
2010: Allison C Sharrow; Brigitte M Ronnett; Christopher J Thoburn; James P Barber; Robert L Giuntoli; Deborah K Armstrong; Richard J Jones; Allan Hess
Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats.
Journal of ovarian research 2010;3():9.
2009: William J Savage; James P Barber; Galina L Mukhina; Rong Hu; Guibin Chen; William Matsui; Chris Thoburn; Allan Hess; Linzhao Cheng; Richard J Jones; Robert A Brodsky
Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.
Experimental hematology 2009;37(1):42-51.
2008: Elisabetta Capriotti; Eric Vonderheid; Christopher J Thoburn; Mariusz A Wasik; David W Bahler; Allan Hess
Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.
Leukemia & lymphoma 2008;49(6):1190-201.
2007: Elisabetta Capriotti; Eric Vonderheid; Christopher J Thoburn; Emilie C Bright; Allan Hess
Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: clinical and histopathological correlations.
The Journal of investigative dermatology 2007;127(12):2882-92.
2007: F. JAVIER BOLANOS MEADE; Elizabeth Garrett-Mayer; Leo Luznik; Viki Anders; Jennifer Webb; Ephraim J Fuchs; Carol Ann Huff; William Matsui; Ivan Borrello; Robert A Brodsky; Yvette L Kasamon; Lode J Swinnen; Ian W Flinn; Richard F Ambinder; Richard J Jones; Allan Hess; Georgia B Vogelsang
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1185-91.
2007: Abdiaziz S Mohamood; Mehmet L Guler; Zuoxiang Xiao; Dongfeng Zheng; Allan Hess; Yi Wang; Hideo Yagita; Jonathan P Schneck; Abdel Rahim A Hamad
Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.
The American journal of pathology 2007;171(1):97-106.
2007: Jesús G Berdeja; Allan Hess; David M Lucas; Paul O'Donnell; Richard F Ambinder; Louis F Diehl; Denise Carter-Brookins; Susan Newton; Ian W Flinn
Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2392-9.
2006: Poorni A De S Muthukumarana; Gary E Lyons; Yuji Miura; Lorraine H Thompson; Tracy Watson; Colin J Green; Sandra Shurey; Allan Hess; Bruce R Rosengard; Su M Metcalfe
Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance.
International immunopharmacology 2006;6(13-14):1993-2001.
2006: Allan Hess; Christopher J Thoburn
Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):518-29.
2006: Allan Hess
Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1 Suppl 2):13-21.
2005: Julie M Wu; Debra Bensen-Kennedy; Yuji Miura; Christopher J Thoburn; Deborah K Armstrong; Georgia B Vogelsang; Allan Hess
The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):455-64.
2005: Allan Hess; Christopher J Thoburn; Yuji Miura; Emilie C Bright
Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen.
Clinical immunology (Orlando, Fla.) 2005;114(3):307-19.
2005: Yuji Miura; Christopher J Thoburn; Emilie C Bright; S Arai; Allan Hess
Regulation of OX40 gene expression in graft-versus-host disease.
Transplantation proceedings 2005;37(1):57-61.
2005: Allan Hess; Christopher J Thoburn; Yuji Miura; Emilie C Bright
Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease.
Transplantation proceedings 2005;37(1):53-6.
2004: Yuji Miura; Christopher J Thoburn; Emilie C Bright; Michele L Phelps; Tae Kwang Shin; Elizabeth C Matsui; William Matsui; Sally Arai; Ephraim J Fuchs; Georgia B Vogelsang; Richard J Jones; Allan Hess
Association of Foxp3 regulatory gene expression with graft-versus-host disease.
Blood 2004;104(7):2187-93.
2004: Christopher J Thoburn; Yuji Miura; Emilie C Bright; Allan Hess
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(9):591-603.
2004: Yuji Miura; Christopher J Thoburn; Emilie C Bright; Allan Hess
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):156-70.
2003: Yuji Miura; M Ueda; Akiyoshi Takami; Shintaro Shiobara; S Nakao; Allan Hess
Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
Bone marrow transplantation 2003;32(8):785-90.
2003: Allan Hess; Christopher J Thoburn; WEIRAN CHEN; And Emilie C Bright
Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
Transplantation 2003;75(8):1361-7.
2002: Yuji Miura; Christopher J Thoburn; Emilie C Bright; WEIRAN CHEN; Shinji Nakao; Allan Hess
Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.
Blood 2002;100(7):2650-8.
2001: Allan Hess; Christopher J Thoburn; WEIRAN CHEN; Yuji Miura; ELSKEN VAN DER WALL
The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigen.
Clinical immunology (Orlando, Fla.) 2001;101(1):67-76.
2001: Yuji Miura; Christopher J Thoburn; Emilie C Bright; M Sommer; S Lefell; M Ueda; Shinji Nakao; Allan Hess
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.
Blood 2001;98(3):868-76.
2001: WEIRAN CHEN; Christopher J Thoburn; Yuji Miura; M Sommer; Ralph Hruban; Zhiping Qian; William M Baldwin; Allan Hess
Autoimmune-mediated vasculopathy.
Clinical immunology (Orlando, Fla.) 2001;100(1):57-70.
2001: Allan Hess; Christopher J Thoburn; WEIRAN CHEN; LR Horwitz
Autoreactive T-Cell subsets in acute and chronic syngeneic graft-versus-host disease.
Transplantation proceedings 2001;33(1-2):1754-6.
2000: ELSKEN VAN DER WALL; T Horn; Emilie C Bright; J L Passos-Coehlo; S Bond; B Clarke; VL Altomonte; K McIntyre; Georgia B Vogelsang; Stephen J Noga; JANICE DAVIS SPROUL; J Thomassen; KV Ohly; S M Lee; John H Fetting; Deborah K Armstrong; Nancy E Davidson; Allan Hess; M John Kennedy
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
British journal of cancer 2000;83(11):1405-11.
2000: Allan Hess
Autologous graft-versus-host disease.
Journal of hematotherapy & stem cell research 2000;9(3):297.
2000: Allan Hess; Christopher J Thoburn; WEIRAN CHEN; LR Horwitz
Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):13-24.
1999: Zhiping Qian; Barbara A Wasowska; E Behrens; DL Cangello; Jonathan R Brody; Shrihari S. Kadkol; LR Horwitz; Jinsong Liu; Charles J Lowenstein; Allan Hess; Alfred P. Sanfilippo; William M Baldwin
C6 produced by macrophages contributes to cardiac allograft rejection.
The American journal of pathology 1999;155(4):1293-302.
1999: Georgia B Vogelsang; R Bitton; Steven Piantadosi; VL Altomonte; T Horn; Richard J Jones; Carole B Miller; Deborah Marcellus; RHODA ABRAMS; Allan Hess
Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
Bone marrow transplantation 1999;24(6):637-40.
1999: Allan Hess; LR Horwitz; Christopher J Thoburn
Immune tolerance to self-MHC class II antigens after bone marrow transplantation.
Transplantation proceedings 1999;31(1-2):688-9.
1999: Christopher J Thoburn; WEIRAN CHEN; LR Horwitz; Allan Hess
Pathogenic specificity of effector T lymphocytes in syngeneic graft-versus-host disease.
Transplantation proceedings 1999;31(1-2):684-6.
1998: WEIRAN CHEN; Christopher J Thoburn; Allan Hess
Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):7040-6.
1998: Paul V O'Donnell; Richard J Jones; Georgia B Vogelsang; A Seber; Richard F Ambinder; Ian W Flinn; Carole B Miller; Deborah Marcellus; Constance A Griffin; RHODA ABRAMS; Hayden Braine; M Grever; Allan Hess; Steven Piantadosi; Stephen J Noga
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
Bone marrow transplantation 1998;22(10):947-55.
1998: Stephen J Noga; A Seber; JANICE DAVIS SPROUL; R J Berenson; Georgia B Vogelsang; Hayden Braine; Allan Hess; Deborah Marcellus; Carole B Miller; Saul J Sharkis; Steven Goodman; G W Santos; Richard J Jones
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment.
Journal of hematotherapy 1998;7(2):151-7.
1998: Allan Hess; Christopher J Thoburn; LR Horwitz
Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells.
Transplantation 1998;65(6):785-92.
1997: Allan Hess; Christopher J Thoburn
Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease.
Immunological reviews 1997;157():111-23.
1997: Allan Hess; Emilie C Bright; Christopher J Thoburn; Georgia B Vogelsang; Richard J Jones; M John Kennedy
Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide.
Blood 1997;89(6):2203-9.
1997: Stephen J Noga; Georgia B Vogelsang; A Seber; JANICE DAVIS SPROUL; K Schepers; Allan Hess; Richard J Jones
CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity.
Transplantation proceedings 1997;29(1-2):728-32.
1997: Allan Hess; Christopher J Thoburn; Emilie C Bright; LR Horwitz
Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP).
Transplantation proceedings 1997;29(1-2):725-7.
1997: Allan Hess; P Ruvolo; A Fischer; LR Horwitz; Emilie C Bright; Christopher J Thoburn
Characterization of the V alpha/V beta autoreactive T-cell repertoire in syngeneic graft-vs-host disease.
Transplantation proceedings 1997;29(1-2):709-11.
1996: S Ibrahim; FM Jakobs; Dilip S Kittur; Allan Hess; Peter Linsley; Alfred P. Sanfilippo; William M Baldwin
CTLA4Ig inhibits alloantibody responses to repeated blood transfusions.
Blood 1996;88(12):4594-600.
1996: W E Beschorner; Z Qian; P Mattei; Allan Hess; Paul M Colombani; A C Sciscione; A Khouzami; Karin J Blakemore; James F Burdick
Induction of human chimerism and functional suppressor cells in fetal pigs: feasibility of surrogate tolerogenesis for xenotransplantation.
Transplantation proceedings 1996;28(2):648-9.
1995: Allan Hess; M J Kennedy; P P Ruvolo; Georgia B Vogelsang; Richard J Jones
Antitumor activity of syngeneic/autologous graft-versus-host disease.
Annals of the New York Academy of Sciences 1995;770():189-202.
1995: M J Kennedy; Allan Hess
Autologous graft-versus-host disease.
Medical oncology (Northwood, London, England) 1995;12(3):149-56.
1995: Huafeng Zhang; LR Horwitz; P Ruvolo; Paul M Colombani; Allan Hess
The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
Transplantation 1995;60(2):115-22.
1995: P P Ruvolo; A C Fischer; Georgia B Vogelsang; Richard J Jones; Allan Hess
Analysis of the V beta T-cell receptor repertoire in autologous graft-versus-host disease.
Annals of the New York Academy of Sciences 1995;756():432-4.
1995: A H Esa; J T Warren; Allan Hess; W S May
Bryostatins trigger human polymorphonuclear neutrophil and monocyte oxidative metabolism: association with in vitro antineoplastic activity.
Research in immunology 1995;146(6):351-61.
1995: Richard K Burt; W Burns; Allan Hess
Bone marrow transplantation for multiple sclerosis.
Bone marrow transplantation 1995;16(1):1-6.
1995: Richard K Burt; W Burns; P Ruvolo; A Fischer; C Shiao; A Guimaraes; J Barrett; Allan Hess
Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis.
Journal of neuroscience research 1995;41(4):526-31.
1995: R B Brauer; T T Lam; D Wang; L R Horwitz; Allan Hess; Andrew S Klein; Alfred P. Sanfilippo; William M Baldwin
Extrahepatic synthesis of C6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograft.
Transplantation 1995;59(7):1073-6.
1995: A C Fischer; P P Ruvolo; R Burt; L R Horwitz; Emilie C Bright; J M Hess; W E Beschorner; Allan Hess
Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(8):3713-25.
1995: C J Thoburn; Allan Hess
Bryostatin can induce antigen-specific nonresponsiveness in human peripheral blood T cells.
Transplantation proceedings 1995;27(1):443-4.
1995: Allan Hess; A C Fischer; L R Horwitz; Emilie C Bright; J M Hess
Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.
Transplantation proceedings 1995;27(1):1370-3.
1995: A C Fischer; P P Ruvolo; L R Horwitz; Allan Hess
Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.
Transplantation proceedings 1995;27(1):1366-9.
1995: P Ruvolo; Emilie C Bright; M J Kennedy; L Morris; A Fischer; Georgia B Vogelsang; Richard J Jones; Allan Hess
Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Transplantation proceedings 1995;27(1):1363-5.
1995: Ephraim J Fuchs; Atul Bedi; Richard J Jones; Allan Hess
Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.
Cancer research 1995;55(3):463-6.
1994: R B Brauer; William M Baldwin; D Wang; L R Horwitz; Allan Hess; Andrew S Klein; Alfred P. Sanfilippo
Hepatic and extrahepatic biosynthesis of complement factor C6 in the rat.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(7):3168-76.
1994: Georgia B Vogelsang; Allan Hess
Graft-versus-host disease: new directions for a persistent problem.
Blood 1994;84(7):2061-7.
1994: TD Horn; D J Bauer; Georgia B Vogelsang; Allan Hess
Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model.
The Journal of investigative dermatology 1994;103(2):206-10.
1994: Allan Hess; A C Fischer; LR Horwitz; Emilie C Bright; M K Laulis
Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(1):400-11.
1994: M J Kennedy; Georgia B Vogelsang; Richard J Jones; Evan Farmer; Allan Hess; VL Altomonte; A M Huelskamp; Nancy E Davidson
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):249-57.
1993: Allan Hess; L R Horwitz; M K Laulis; Ephraim J Fuchs
Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
Clinical immunology and immunopathology 1993;69(3):341-50.
1993: A M Yeager; Georgia B Vogelsang; Richard J Jones; Evan Farmer; Allan Hess; G W Santos
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
Leukemia & lymphoma 1993;11(3-4):215-20.
1993: Allan Hess; A C Fischer; L R Horwitz; M K Laulis
Cyclosporine-induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibility class II-dependent autoaggression.
Transplantation proceedings 1993;25(5):2811-3.
1993: Stephen J Noga; Allan Hess
Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host disease prove to be superior to prevention?
Seminars in oncology 1993;20(5 Suppl 6):28-33.
1993: J M Pozsgay; M W Beilharz; B D Wines; Allan Hess; PAULA PITHA-ROWE
The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus.
Journal of virology 1993;67(10):5989-99.
1993: Sammy H Liu; D H Zhou; Allan Hess
Adoptive transfer of experimental autoimmune dacryoadenitis in susceptible and resistant mice.
Cellular immunology 1993;150(2):311-20.
1993: Allan Hess
Mechanisms of action of cyclosporine: considerations for the treatment of autoimmune diseases.
Clinical immunology and immunopathology 1993;68(2):220-8.
1993: Sammy H Liu; D H Zhou; John D Gottsch; Allan Hess
Treatment of experimental autoimmune dacryoadenitis with cyclosporin A.
Clinical immunology and immunopathology 1993;67(1):78-83.
1993: Allan Hess; L R Horwitz; M K Laulis
Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Transplantation proceedings 1993;25(1 Pt 2):1218-21.
1993: Georgia B Vogelsang; Allan Hess
Rapamycin effects on immunologic reconstitution.
Transplantation proceedings 1993;25(1 Pt 1):727-8.
1993: M E Severino; M K Laulis; L R Horwitz; Allan Hess
Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
Transplantation proceedings 1993;25(1 Pt 1):520-3.
1993: Allan Hess; R C Jones; G W Santos
Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
Bone marrow transplantation 1993;12 Suppl 3():S65-9.
1992: Allan Hess; Richard J Jones; L E Morris; Stephen J Noga; Georgia B Vogelsang; G W Santos
Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy.
Human immunology 1992;34(3):219-24.
1992: A M Yeager; Georgia B Vogelsang; Richard J Jones; Evan Farmer; VL Altomonte; Allan Hess; G W Santos
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
Blood 1992;79(11):3031-5.
1992: Georgia B Vogelsang; Evan Farmer; Allan Hess; V Altamonte; W E Beschorner; D A Jabs; RUSSELL CORIO; L S Levin; O Michael Colvin; John R Wingard
Thalidomide for the treatment of chronic graft-versus-host disease.
The New England journal of medicine 1992;326(16):1055-8.
1992: Allan Hess; Richard J Jones; L E Morris; Stephen J Noga; A M Yeager; Georgia B Vogelsang; G W Santos
Autologous graft-versus-host disease: a new frontier in immunotherapy.
Bone marrow transplantation 1992;10 Suppl 1():16-21.
1992: Stephen J Noga; LR Horwitz; H Kim; M K Laulis; Allan Hess
Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity.
Journal of hematotherapy 1992;1(1):75-84.
1991: B L Levine; W S May; P G Tyler; Allan Hess
Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(10):3474-81.
1991: W E Beschorner; H Ren; J Phillips; H B Pulido; Ralph Hruban; Allan Hess
Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporine.
Transplantation 1991;52(4):668-74.
1991: Allan Hess; Emilie C Bright
The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Transplantation 1991;51(6):1232-40.
1991: Allan Hess; Emilie C Bright
Cyclosporine inhibits T-cell activation at two distinct levels: role of the CD 28 activation pathway.
Transplantation proceedings 1991;23(1 Pt 2):961-6.
1991: L M Schuchter; A H Esa; S May; M K Laulis; George R Pettit; Allan Hess
Successful treatment of murine melanoma with bryostatin 1.
Cancer research 1991;51(2):682-7.
1991: A C Fischer; M K Laulis; LR Horwitz; Allan Hess
Effect of cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease.
Transplantation 1991;51(1):252-9.
1990: Allan Hess; A C Fischer; W E Beschorner
Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(2):526-33.
1990: A C Fischer; Allan Hess
Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes.
The Journal of experimental medicine 1990;172(1):85-94.
1990: T Shinozawa; W E Beschorner; Allan Hess
The thymus and prolonged administration of cyclosporine. Irreversible immunopathologic changes associated with autologous pseudo-graft-versus-host disease.
Transplantation 1990;50(1):106-11.
1990: A H Esa; W O Boto; W H Adler; W S May; Allan Hess
Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
International journal of immunopharmacology 1990;12(5):481-90.
1990: Stephen J Noga; A C Fischer; L R Horwitz; A D Donnenberg; J E Wagner; Allan Hess
Elutriation of bone marrow delineates two distinct natural suppressor cell populations.
Progress in clinical and biological research 1990;333():363-8.
1990: Stephen J Noga; J E Wagner; S D Rowley; JANICE DAVIS SPROUL; Georgia B Vogelsang; Allan Hess; R Saral; G W Santos; A D Donnenberg
Using elutriation to engineer bone marrow allografts.
Progress in clinical and biological research 1990;333():345-59; discussion 360-1.
1989: Allan Hess; A C Fischer
Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
Transplantation 1989;48(6):895-900.
1989: R B Geller; A H Esa; W E Beschorner; Carmelita G Frondoza; G W Santos; Allan Hess
Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.
Blood 1989;74(3):1165-71.
1989: A C Fischer; M K Laulis; LR Horwitz; W E Beschorner; Allan Hess
Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(3):827-32.
1989: Georgia B Vogelsang; Allan Hess; Kenneth Friedman; G W Santos
Therapy of chronic graft-v-host disease in a rat model.
Blood 1989;74(1):507-11.
1989: Richard J Jones; Georgia B Vogelsang; Allan Hess; Evan Farmer; Risa B Mann; R B Geller; Steven Piantadosi; G W Santos
Induction of graft-versus-host disease after autologous bone marrow transplantation.
Lancet 1989;1(8641):754-7.
1989: A C Fischer; W E Beschorner; Allan Hess
Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease.
The Journal of experimental medicine 1989;169(3):1031-41.
1989: M S Wells; Georgia B Vogelsang; Paul M Colombani; Allan Hess
Cyclosporin A binding to calmodulin.
Transplantation proceedings 1989;21(1 Pt 1):850-2.
1989: Paul M Colombani; Emilie C Bright; M Wells; Allan Hess
Drug-drug interaction between cyclosporine and agents affecting calcium-dependent lymphocyte proliferation.
Transplantation proceedings 1989;21(1 Pt 1):840-1.
1989: A C Fischer; W E Beschorner; Allan Hess
Age-related factors in the induction of syngeneic GVHD.
Transplantation proceedings 1989;21(1 Pt 3):3033-5.
1989: Georgia B Vogelsang; Richard J Jones; Allan Hess; R Geller; L Schucter; G W Santos
Induction of autologous graft-versus-host disease.
Transplantation proceedings 1989;21(1 Pt 3):2997-8.
1989: Allan Hess; A C Fischer; W E Beschorner
Regulation of syngeneic graft-versus-host disease by autosuppressor mechanisms.
Transplantation proceedings 1989;21(1 Pt 3):3013-5.
1989: W E Beschorner; C A Shinn; Allan Hess; D L Suresch; G W Santos
Immune-related injury to endothelium associated with acute graft-versus-host disease in the rat.
Transplantation proceedings 1989;21(1 Pt 3):3025-7.
1989: Leonard W. Scheibel; Paul M Colombani; Allan Hess; M Aikawa; C T Atkinson; I Igarashi; Y Matsumoto; W K Milhous
Calcium/calmodulin functions in P. falciparum in vitro--implications for antiprotozoal drug design.
Progress in clinical parasitology 1989;1():21-56.
1988: D A Newsome; Thomas C Quinn; Allan Hess; PAULA PITHA-ROWE
Cellular immune status in retinitis pigmentosa.
Ophthalmology 1988;95(12):1696-703.
1988: Allan Hess; M K Silanskis; A H Esa; George R Pettit; W S May
Activation of human T lymphocytes by bryostatin.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(10):3263-9.
1988: Georgia B Vogelsang; Allan Hess; G W Santos
Thalidomide for treatment of graft-versus-host disease.
Bone marrow transplantation 1988;3(5):393-8.
1988: W E Beschorner; C A Shinn; A C Fischer; G W Santos; Allan Hess
Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period.
Transplantation 1988;46(2 Suppl):112S-117S.
1988: Allan Hess; Paul M Colombani
Inverse correlation of cyclosporine binding with sensitivity and resistance.
Transplantation 1988;46(2 Suppl):61S-67S.
1988: W E Beschorner; D L Suresch; T Shinozawa; G W Santos; Allan Hess
Thymic immunopathology after cyclosporine: effect of irradiation and age on medullary involution and recovery.
Transplantation proceedings 1988;20(3 Suppl 3):1072-8.
1988: A C Fischer; W E Beschorner; Allan Hess
Syngeneic graft-versus-host disease: failure of autoregulation in self/non-self discrimination.
Transplantation proceedings 1988;20(3 Suppl 3):493-500.
1988: Allan Hess; Georgia B Vogelsang; M Silanskis; K A Friedman; W E Beschorner; G W Santos
Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
Transplantation proceedings 1988;20(3 Suppl 3):487-92.
1988: Stephen J Noga; A C Fischer; J E Wagner; S J Normann; J R Zucali; A E Esa; Allan Hess
Cyclosporine A enhances the natural suppressor monocyte precursor population in the rat.
Transplantation proceedings 1988;20(3 Suppl 3):1057-67.
1988: Georgia B Vogelsang; Allan Hess; G W Santos
Acute graft-versus-host disease: clinical characteristics in the cyclosporine era.
Medicine 1988;67(3):163-74.
1988: Georgia B Vogelsang; M C Wells; G W Santos; T L Chen; Allan Hess
Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model.
Transplantation proceedings 1988;20(2 Suppl 2):226-8.
1988: W E Beschorner; J L Olson; Allan Hess; K A Di Gennaro; G W Santos
Cyclosporine-induced cell-mediated injury of the thymic medullary epithelium.
Transplantation 1988;45(4):797-803.
1988: A H Esa; D G Paxman; Stephen J Noga; Allan Hess
Sensitivity of monocyte subpopulations to cyclosporine. Arachidonate metabolism and in vitro antigen presentation.
Transplantation proceedings 1988;20(2 Suppl 2):80-6.
1988: Paul M Colombani; Emilie C Bright; Allan Hess
Comparison of binding to peripheral blood lymphocytes between active and inactive derivatives of cyclosporine.
Transplantation proceedings 1988;20(2 Suppl 2):46-50.
1988: Allan Hess; A H Esa; Paul M Colombani
Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.
Transplantation proceedings 1988;20(2 Suppl 2):29-40.
1988: J E Wagner; A D Donnenberg; Stephen J Noga; J M Wiley; A M Yeager; Georgia B Vogelsang; Allan Hess; G W Santos
Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion.
Experimental hematology 1988;16(3):206-12.
1988: Stephen J Noga; J E Wagner; L R Horwitz; A D Donnenberg; G W Santos; Allan Hess
Characterization of the natural suppressor cell population in adult rat bone marrow.
Journal of leukocyte biology 1988;43(3):279-87.
1988: W E Beschorner; Allan Hess; C A Shinn; G W Santos
Transfer of cyclosporine-associated syngeneic graft-versus-host disease by thymocytes. Resemblance to chronic graft-versus-host disease.
Transplantation 1988;45(1):209-15.
1987: W E Beschorner; K A Di Gennaro; Allan Hess; G W Santos
Cyclosporine and the thymus: influence of irradiation and age on thymic immunopathology and recovery.
Cellular immunology 1987;110(2):350-64.
1987: A D Donnenberg; Allan Hess; S C Duff; Emilie C Bright; Stephen J Noga; S D Rowley; R Saral; G W Santos
Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxis.
Transplantation proceedings 1987;19(6 Suppl 7):144-52.
1987: Paul M Colombani; Allan Hess
T-lymphocyte inhibition by cyclosporine. Potential mechanisms of action.
Biochemical pharmacology 1987;36(22):3789-93.
1987: Leonard W. Scheibel; Paul M Colombani; Allan Hess; M Aikawa; C T Atkinson; W K Milhous
Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(20):7310-4.
1987: Allan Hess; Paul M Colombani
Cyclosporin-resistant and -sensitive T-lymphocyte subsets.
Annales de l'Institut Pasteur. Immunology 1987;138(4):606-11.
1987: W E Beschorner; J D Namnoum; Allan Hess; C A Shinn; G W Santos
Cyclosporin A and the thymus. Immunopathology.
The American journal of pathology 1987;126(3):487-96.
1987: Allan Hess; Georgia B Vogelsang; J Heyd; W E Beschorner
Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
Transplantation proceedings 1987;19(1 Pt 3):2683-6.
1987: Georgia B Vogelsang; Allan Hess; G Gordon; R Brundrette; G W Santos
Thalidomide induction of bone marrow transplantation tolerance.
Transplantation proceedings 1987;19(1 Pt 3):2658-61.
1987: W E Beschorner; J D Namnoum; Allan Hess
Immunopathology of rat thymus after cyclosporine A.
Transplantation proceedings 1987;19(1 Pt 2):1230-5.
1987: A H Esa; Georgia B Vogelsang; GORDON SANDFORD; R Saral; Allan Hess; W H Burns
Cell-mediated immune responses in rat cytomegalovirus infection.
Transplantation proceedings 1987;19(1 Pt 3):2726-9.
1987: Paul M Colombani; Emilie C Bright; O Monastyrskyj; Allan Hess
Subcellular action of cyclosporine: interaction between CsA and calmodulin antagonists.
Transplantation proceedings 1987;19(1 Pt 2):1171-4.
1987: Adorjan Aszalos; S Damjanovich; Paul M Colombani; Allan Hess
Lymphocyte populations with different sensitivity to cyclosporin have different plasma membrane potentials.
Journal of medicine 1987;18(5-6):351-74.
1987: A H Esa; Paul J Converse; Allan Hess
Cyclosporine inhibits soluble antigen and alloantigen presentation by human monocytes in vitro.
International journal of immunopharmacology 1987;9(8):893-902.
1987: Allan Hess; Paul M Colombani
Mechanism of action of cyclosporine: a unifying hypothesis.
Advances in experimental medicine and biology 1987;213():309-30.
1987: Paul M Colombani; Allan Hess
Fluorometric and flow cytometric analysis of the cyclosporine-calmodulin interaction in T lymphocytes.
Methods in enzymology 1987;139():677-90.
1986: Allan Hess; Paul M Colombani
Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
Transplantation proceedings 1986;18(6 Suppl 5):219-37.
1986: A H Esa; Stephen J Noga; A D Donnenberg; Allan Hess
Immunological heterogeneity of human monocyte subsets prepared by counterflow centrifugation elutriation.
Immunology 1986;59(1):95-9.
1986: Paul M Colombani; Allan Hess
Response: calmodulin, cyclophilin, and cyclosporin a.
Science (New York, N.Y.) 1986;233(4767):988-9.
1986: Georgia B Vogelsang; Allan Hess; G Gordon; G W Santos
Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model.
Transplantation 1986;41(5):644-7.
1986: J W Simons; Stephen J Noga; Paul M Colombani; W E Beschorner; Donald S Coffey; Allan Hess
Cyclosporine A, an in vitro calmodulin antagonist, induces nuclear lobulations in human T cell lymphocytes and monocytes.
The Journal of cell biology 1986;102(1):145-50.
1986: Allan Hess; Paul M Colombani; A H Esa
Cyclosporine and the immune response: basic aspects.
Critical reviews in immunology 1986;6(2):123-49.
1986: Allan Hess; Paul M Colombani
Cyclosporin. Mechanism of action: in vitro studies.
Progress in allergy 1986;38():198-221.
1985: G W Santos; Allan Hess; Georgia B Vogelsang
Graft-versus-host reactions and disease.
Immunological reviews 1985;88():169-92.
1985: Georgia B Vogelsang; Allan Hess; A W Berkman; P J Tutschka; Evan Farmer; Paul J Converse; G W Santos
An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants.
The New England journal of medicine 1985;313(11):645-50.
1985: Paul M Colombani; A Robb; Allan Hess
Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.
Science (New York, N.Y.) 1985;228(4697):337-9.
1985: Allan Hess; L Horwitz; W E Beschorner; G W Santos
Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.
The Journal of experimental medicine 1985;161(4):718-30.
1985: Paul J Converse; Allan Hess
Effect of cyclosporin and interleukin-2 on the restoration of in vitro immune responses to cytomegalovirus.
Scandinavian journal of immunology 1985;21(2):109-18.
1985: Allan Hess
Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
Transplantation 1985;39(1):62-8.
1985: Allan Hess; G W Santos
Induction of suppressor lymphocytes in lymphohematopoietic chimeras.
The Year in immunology 1985;():51-61.
1984: A Glazier; W L Morison; C Bucana; Allan Hess; J Tutschka
Suppression of epidermal graft-versus-host disease with ultraviolet radiation.
Transplantation 1984;37(2):211-3.
1983: Paul J Converse; Allan Hess; P J Tutschka; G W Santos
Effect of cyclosporine on the response of normal human lymphocytes to cytomegalovirus in vitro.
Infection and immunity 1983;41(3):1226-33.
1983: J R Wingard; Allan Hess; Robert Stuart; R Saral; W H Burns
Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation.
Antimicrobial agents and chemotherapy 1983;23(4):593-7.
1983: P J Tutschka; W E Beschorner; Allan Hess; G W Santos
Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants.
Blood 1983;61(2):318-25.
1983: Allan Hess; A D Donnenberg; P J Tutschka; G W Santos
Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(2):717-21.
1982: M Körbling; Allan Hess; P J Tutschka; H Kaizer; M O Colvin; G W Santos
4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graft.
British journal of haematology 1982;52(1):89-96.
1982: P J Tutschka; Allan Hess; W E Beschorner; G W Santos
Suppressor cells in transplantation tolerance. III. The role of antigen in the maintenance of transplantation tolerance.
Transplantation 1982;33(5):510-4.
1982: Allan Hess; P J Tutschka; Z Pu; G W Santos
Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(1):360-7.
1982: Allan Hess; P J Tutschka; G W Santos
Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(1):355-9.
1982: Allan Hess
Cyclosporin A and the immune response to transplantation antigens.
Lymphokine research 1982;1(2):23-7.
1981: P J Tutschka; P F Ki; W E Beschorner; Allan Hess; G W Santos
Suppressor cells in transplantation tolerance. II. maturation of suppressor cells in the bone marrow chimera.
Transplantation 1981;32(4):321-5.
1981: P J Tutschka; Allan Hess; W E Beschorner; G W Santos
Suppressor cells in transplantation tolerance. I. Suppressor cells in the mechanism of tolerance in radiation chimeras.
Transplantation 1981;32(3):203-9.
1981: Allan Hess; P J Tutschka; G W Santos
In vitro activation of human suppressor cells: relative quantitation and specificity of suppressor cells generated in primary and secondary mixed lymphocyte cultures.
Experimental hematology 1981;9(4):415-30.
1981: P J Tutschka; M Körbling; Allan Hess; W E Beschorner; G W Santos
Prevention of graft-versus-host disease (GVHD) by chemoseparation of marrow cells.
Transplantation proceedings 1981;13(1 Pt 2):1202-6.
1981: Allan Hess; P J Tutschka; G W Santos
Effect of cyclosporin-A on human lymphocyte responses in vitro--induction of tolerance to alloantigens.
Transplantation proceedings 1981;13(1 Pt 1):374-8.
1981: Allan Hess; P J Tutschka; G W Santos
Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(3):961-8.
1981: W J Hubbard; Allan Hess; S Hsia; D B Amos
The effects of electrophoretically "slow" and "fast" alpha-2 macroglobulin on mixed lymphocyte cultures.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(1):292-9.
1980: Allan Hess; S A Gall; J R Dawson
Inhibition of human lymphoblastoid cell line proliferation by ascites fluids from ovarian cancer patients.
Cancer research 1980;40(12):4495-500.
1980: A R Zander; S Sarpell; B Cunningham; Allan Hess; D A Johnston; R B Epstein
Plasmapheresis as immunotherapeutic modality in the treatment of the canine venereal tumor.
Experimental hematology 1980;8(9):1123-8.
1980: Allan Hess; S A Gall; J R Dawson
Partial purification and characterization of a lymphocyte-inhibitory factor(s) in ascitic fluids from ovarian cancer patients.
Cancer research 1980;40(6):1842-51.
1980: Allan Hess; P J Tutschka
Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(6):2601-8.
1980: P J Tutschka; W E Beschorner; Allan Hess
Use of cyclosporin A (CsA) in a rat model of allogeneic marrow transplantation.
Haematology and blood transfusion 1980;25():241-53.
1980: A R Zander; Allan Hess; R B Epstein
Immunosuppressive effects of rabbit anti-canine brain serum.
Experimentelle Pathologie 1980;18(5):310-3.
1979: W E Beschorner; Allan Hess; S T Nerenberg; R B Epstein
Isolation and characterization of canine venereal tumor-associated inhibitory and blocking factors.
Cancer research 1979;39(10):3920-7.
1979: Allan Hess; S A Gall; J R Dawson
Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients.
Cancer research 1979;39(7 Pt 1):2381-9.
1977: Allan Hess; R Catchatourian; A R Zander; R B Epstein
Intralesional Bacillus Calmette-Guérin immunotherapy of canine venereal tumors.
Cancer research 1977;37(11):3990-4.
1975: Allan Hess; B Cunningham; B Taylor Bennett; R Epstein
In vitro correlates of the in vivo course of the canine transmissible venereal tumor studied by mixed lymphocyte-tumor cultures.
Transplantation proceedings 1975;7(4):507-11.